Marc Carrier/X
Apr 13, 2026, 12:48
Marc Carrier: The Vermont Model Demonstrates the Power of VTE Prevention
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article by Chris Holmes et al, published in JCO Oncology Practice:
”Real-world evidence confirms what trials have shown: guideline-based VTE prevention matters.
In high-risk ambulatory cancer patients, a multidisciplinary program (‘Vermont model‘) led to:
- VTE: 3.2% vs 7.7% (OR 0.36)
- 6-month mortality: 16.8% vs 31.3% (OR 0.46)
- Despite strong evidence, uptake remains suboptimal, closing this gap is an immediate opportunity to improve outcomes in cancer care.”
Title: Impact of Venous Thrombosis Prevention in Ambulatory Oncology: Importance of Guideline Adherence
Authors: Chris Holmes, Karlyn Martin, Derek Devine, Jacob Barker, Peter Callas, Karen Libby, Emily Parenteau, Mary Cushman, Steven Ades
Read the Full Article on JCO Oncology Practice

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026